Clinical Trials Directory

Trials / Unknown

UnknownNCT01499472

Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot Ulcers

ESWT Treatment of Diabetic Foot VS. Standard Care Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if Extra-corporeal-shockwave Therapy (ESWT) added to standard of care wound therapy significantly improves time to complete wound healing in diabetic foot wounds.

Conditions

Interventions

TypeNameDescription
DEVICEshock wave therapyshock wave therapy given in accordance to wound assessment every 2 weeks for 4 treatments.
DEVICEdermagold shockwaveshock wave therapy given in accordance to wound assessment every 2 weeks for 4 treatments.
PROCEDUREstandard of careregular care including debridement and bandaging.

Timeline

Start date
2012-01-01
Primary completion
2013-01-01
Completion
2015-01-01
First posted
2011-12-26
Last updated
2011-12-26

Source: ClinicalTrials.gov record NCT01499472. Inclusion in this directory is not an endorsement.

Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabet (NCT01499472) · Clinical Trials Directory